agreement. i will say at this point senators sinema and manchin are not signed on. they have spoken positively about it. they are not to yes at this point in time. real quickly, abouting to the specifics on the drug pricing. is what you are saying that medicare could negotiate drugs on the market long enough that there are generic versions but not drugs that are pretty new so they have exclusivity. is that what you are saying? . that has been the crux of the debate. whether we should negotiate for a more narrow range of drugs for which the research has long been paid off. i think there is a debate as to whether or not we should have more patent protections, more exclusivity when there is still a lot of research. taking one example, insulin, we ought to be able to negotiate drug pricing for insulin. this is something americans know when they go to buy it over the counter cost far more than it cost the producers to deliver it to the market. we cannot have billions and billions of dolla